培美曲塞-话题@MedSci

#培美曲塞#

31篇内容 | 2035人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1395288, encodeId=40c51395288cf, content=<a href='/topic/show?id=0e7041632f3' target=_blank style='color:#2F92EE;'>#培美曲塞#</a>, objectTitle=Eur Respir J：晚期非小细胞肺癌患者培美曲塞维持治疗期间的肾功能损害, objectType=article, longId=151992, objectId=4ba115199244, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ba115199244, replyNumber=0, likeNumber=68, createdTime=2018-10-29, rootId=0, userName=12498dabm77暂无昵称, userId=78c32500188, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ba115199244, moduleTitle=Eur Respir J：晚期非小细胞肺癌患者培美曲塞维持治疗期间的肾功能损害, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ba115199244)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395287, encodeId=b625139528e77, content=<a href='/topic/show?id=0e7041632f3' target=_blank style='color:#2F92EE;'>#培美曲塞#</a>, objectTitle=Plos One：预测培美曲塞加铂类对晚期肺腺癌患者疗效的新方法！, objectType=article, longId=101567, objectId=c6bc10156e4e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6bc10156e4e, replyNumber=0, likeNumber=97, createdTime=2017-06-13, rootId=0, userName=12498dabm77暂无昵称, userId=78c32500188, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6bc10156e4e, moduleTitle=Plos One：预测培美曲塞加铂类对晚期肺腺癌患者疗效的新方法！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6bc10156e4e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395286, encodeId=7da0139528617, content=<a href='/topic/show?id=0e7041632f3' target=_blank style='color:#2F92EE;'>#培美曲塞#</a>, objectTitle=ESMO 2016：卡铂+培美曲塞+派姆单抗，可改善NSCLC患者的PFS, objectType=article, longId=79863, objectId=3fa9e98630a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fa9e98630a, replyNumber=0, likeNumber=76, createdTime=2016-10-13, rootId=0, userName=12498dabm77暂无昵称, userId=78c32500188, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fa9e98630a, moduleTitle=ESMO 2016：卡铂+培美曲塞+派姆单抗，可改善NSCLC患者的PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fa9e98630a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395285, encodeId=438b1395285d5, content=<a href='/topic/show?id=0e7041632f3' target=_blank style='color:#2F92EE;'>#培美曲塞#</a>, objectTitle=吉非替尼联合培美曲塞一线治疗EGFR突变的东亚晚期NSCLC患者优于单纯吉非替尼（JMIT研究）, objectType=article, longId=56652, objectId=5e4b5665248, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e4b5665248, replyNumber=0, likeNumber=52, createdTime=2015-09-29, rootId=0, userName=12498dabm77暂无昵称, userId=78c32500188, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e4b5665248, moduleTitle=吉非替尼联合培美曲塞一线治疗EGFR突变的东亚晚期NSCLC患者优于单纯吉非替尼（JMIT研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e4b5665248)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395284, encodeId=e8211395284cc, content=<a href='/topic/show?id=0e7041632f3' target=_blank style='color:#2F92EE;'>#培美曲塞#</a>, objectTitle=JCO：培美曲塞联合顺铂治疗晚期宫颈癌安全有效, objectType=article, longId=38730, objectId=486438e3037, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=486438e3037, replyNumber=0, likeNumber=83, createdTime=2014-08-08, rootId=0, userName=12498dabm77暂无昵称, userId=78c32500188, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=486438e3037, moduleTitle=JCO：培美曲塞联合顺铂治疗晚期宫颈癌安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=486438e3037)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395283, encodeId=3b4e1395283c1, content=<a href='/topic/show?id=0e7041632f3' target=_blank style='color:#2F92EE;'>#培美曲塞#</a>, objectTitle=EJC：培美曲塞+埃罗替尼可改善非鳞状NSCLC生存, objectType=article, longId=36798, objectId=18bc36e9818, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18bc36e9818, replyNumber=0, likeNumber=96, createdTime=2014-06-22, rootId=0, userName=12498dabm77暂无昵称, userId=78c32500188, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18bc36e9818, moduleTitle=EJC：培美曲塞+埃罗替尼可改善非鳞状NSCLC生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18bc36e9818)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395282, encodeId=5695139528236, content=<a href='/topic/show?id=0e7041632f3' target=_blank style='color:#2F92EE;'>#培美曲塞#</a>, objectTitle=英国法院裁决阿特维斯培美曲塞仿制药不侵犯礼来专利权, objectType=article, longId=35112, objectId=85dc3511216, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85dc3511216, replyNumber=0, likeNumber=0, createdTime=2014-05-24, rootId=0, userName=12498dabm77暂无昵称, userId=78c32500188, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85dc3511216, moduleTitle=英国法院裁决阿特维斯培美曲塞仿制药不侵犯礼来专利权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85dc3511216)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395281, encodeId=8b66139528159, content=<a href='/topic/show?id=0e7041632f3' target=_blank style='color:#2F92EE;'>#培美曲塞#</a>, objectTitle=WCLC 2013：EGFR野生型NSCLC二线治疗中培美曲塞优于吉非替尼（CTONG 0806研究）, objectType=article, longId=26015, objectId=e591260152f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e591260152f, replyNumber=0, likeNumber=68, createdTime=2013-11-01, rootId=0, userName=12498dabm77暂无昵称, userId=78c32500188, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e591260152f, moduleTitle=WCLC 2013：EGFR野生型NSCLC二线治疗中培美曲塞优于吉非替尼（CTONG 0806研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e591260152f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395280, encodeId=7b3a1395280fe, content=<a href='/topic/show?id=0e7041632f3' target=_blank style='color:#2F92EE;'>#培美曲塞#</a>, objectTitle=Lung cancer：培美曲塞化疗不需要因补充叶酸而延迟, objectType=article, longId=20443, objectId=699c204430a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=699c204430a, replyNumber=0, likeNumber=80, createdTime=2013-06-23, rootId=0, userName=12498dabm77暂无昵称, userId=78c32500188, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=699c204430a, moduleTitle=Lung cancer：培美曲塞化疗不需要因补充叶酸而延迟, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=699c204430a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395279, encodeId=24c113952e9c2, content=<a href='/topic/show?id=0e7041632f3' target=_blank style='color:#2F92EE;'>#培美曲塞#</a>, objectTitle=ASCO 2013：培美曲塞二线治疗EGFR野生型NSCLC优于吉非替尼, objectType=article, longId=19770, objectId=349119e7046, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=349119e7046, replyNumber=0, likeNumber=68, createdTime=2013-06-08, rootId=0, userName=12498dabm77暂无昵称, userId=78c32500188, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=349119e7046, moduleTitle=ASCO 2013：培美曲塞二线治疗EGFR野生型NSCLC优于吉非替尼, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=349119e7046)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395278, encodeId=457713952e8ae, content=<a href='/topic/show?id=0e7041632f3' target=_blank style='color:#2F92EE;'>#培美曲塞#</a>, objectTitle=Ann Oncol：ALK不影响培美曲塞抗晚期非小细胞肺癌效果, objectType=article, longId=9043, objectId=b9be904317, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9be904317, replyNumber=0, likeNumber=68, createdTime=2012-08-18, rootId=0, userName=12498dabm77暂无昵称, userId=78c32500188, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9be904317, moduleTitle=Ann Oncol：ALK不影响培美曲塞抗晚期非小细胞肺癌效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9be904317)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395277, encodeId=b76f13952e732, content=<a href='/topic/show?id=0e7041632f3' target=_blank style='color:#2F92EE;'>#培美曲塞#</a>, objectTitle=培美曲塞治疗后发生的伴有软组织坏死的放疗后回忆反应性皮炎, objectType=article, longId=2651, objectId=f8572651d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8572651d4, replyNumber=0, likeNumber=79, createdTime=2011-06-09, rootId=0, userName=12498dabm77暂无昵称, userId=78c32500188, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8572651d4, moduleTitle=培美曲塞治疗后发生的伴有软组织坏死的放疗后回忆反应性皮炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8572651d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

培美曲塞

2020-05-29

12498dabm77暂无昵称 (审核中...)

前往app查看评论内容

#培美曲塞#

Eur Respir J：晚期非小细胞肺癌患者培美曲塞维持治疗期间的肾功能损害

2018-10-29

12498dabm77暂无昵称 (审核中...)

前往app查看评论内容

#培美曲塞#

Plos One：预测培美曲塞加铂类对晚期肺腺癌患者疗效的新方法！

2017-06-13

12498dabm77暂无昵称 (审核中...)

前往app查看评论内容

#培美曲塞#

ESMO 2016：卡铂+培美曲塞+派姆单抗，可改善NSCLC患者的PFS

2016-10-13

12498dabm77暂无昵称 (审核中...)

前往app查看评论内容

#培美曲塞#

吉非替尼联合培美曲塞一线治疗EGFR突变的东亚晚期NSCLC患者优于单纯吉非替尼（JMIT研究）

2015-09-29

12498dabm77暂无昵称 (审核中...)

前往app查看评论内容

#培美曲塞#

JCO：培美曲塞联合顺铂治疗晚期宫颈癌安全有效

2014-08-08

12498dabm77暂无昵称 (审核中...)

前往app查看评论内容

#培美曲塞#

EJC：培美曲塞+埃罗替尼可改善非鳞状NSCLC生存

2014-06-22

12498dabm77暂无昵称 (审核中...)

前往app查看评论内容

#培美曲塞#

英国法院裁决阿特维斯培美曲塞仿制药不侵犯礼来专利权

2014-05-24

12498dabm77暂无昵称 (审核中...)

前往app查看评论内容

#培美曲塞#

WCLC 2013：EGFR野生型NSCLC二线治疗中培美曲塞优于吉非替尼（CTONG 0806研究）

2013-11-01

12498dabm77暂无昵称 (审核中...)

前往app查看评论内容

#培美曲塞#

Lung cancer：培美曲塞化疗不需要因补充叶酸而延迟

2013-06-23

12498dabm77暂无昵称 (审核中...)

前往app查看评论内容

#培美曲塞#

ASCO 2013：培美曲塞二线治疗EGFR野生型NSCLC优于吉非替尼

2013-06-08

12498dabm77暂无昵称 (审核中...)

前往app查看评论内容

#培美曲塞#

Ann Oncol：ALK不影响培美曲塞抗晚期非小细胞肺癌效果

2012-08-18

12498dabm77暂无昵称 (审核中...)

前往app查看评论内容

#培美曲塞#

培美曲塞治疗后发生的伴有软组织坏死的放疗后回忆反应性皮炎

2011-06-09

科室
- - 订阅+
  - 更多科室
工具
服务